4CPS-129 Real-life effectiveness and safety of niraparib and olaparib in high-grade ovarian cancer

Autor: R De Santiago Álvarez, C Hernández Terciado, JI Alcaraz López, C Lozano Llano, L Delgado Téllez De Cepeda, B Menchén Viso, C Folguera Olias, M Manso Manrique, C Maximiano Alonso, A Sánchez Guerrero

Publikováno v: Late breaking abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::050d660bab0baf9e18f52de4e5b3fa8b
https://doi.org/10.1136/ejhpharm-2023-eahp.403

CP-163 Analysis of the side effects and the treatment discontinuation of dimethyl fumarate in a tertiary hospital

Autor: C Folguera Olias, A de Rivas Bravo, B. Menchén Viso, A Maestro Nombela, A Martín Alonso, A Sánchez Guerrero

Publikováno v: European Journal of Hospital Pharmacy. 23:A72.1-A72

Background Multiple sclerosis (MS) involves an immune mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system. For years, MS has been treated only with intravenous drugs. For this re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bb5091d0d0892455986357160f09957
https://doi.org/10.1136/ejhpharm-2016-000875.163

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical Practice.

Autor: Calvo Moya M; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., González Lama Y; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Ruíz Antorán B; Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Omella Usieto I; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., El Hajra Martinez I; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Santos Pérez E; Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Menchén Viso B; Hospital Pharmacy Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Matallana Royo V; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., González Partida I; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., de Lucas Tellez de Meneses R; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Bella Castillo P; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., González Rodriguez M; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Vera Mendoza MI; Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Publikováno v: Crohn's & colitis 360 [Crohns Colitis 360] 2023 Jan 10; Vol. 5 (1), pp. otac051. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2023).